There are now medications to treat heart attacks and strokes.

Scientists in Khimki, a suburb of Moscow, have successfully developed an anticoagulant drug that could save many lives.

This anticoagulant drug, developed by Russian scientists over three years, is called "Tiareksaban". The new drug was presented at the International Medical Summit in Berlin and has been highly praised by the international scientific community.

Blood clots can cause heart attacks or strokes.

The drug "Tiareksaban" significantly reduces the risk of blood clots. In fact, these blood clots are quite dangerous. They typically form in veins and arteries after surgery. The clotted blood acts as a kind of plug, preventing blood from flowing through the vessel. This can lead to a heart attack or stroke. Blood clots are among the most common causes of death worldwide. The drug, developed by scientists in the suburbs of Moscow, will control these blood clots.

One of the main advantages of the new product is its safety. Meanwhile, the risk of bleeding while using similar medications is quite high. In addition, "Tiareksaban" will be 25% cheaper than imported analogues.

The new product will be available for sale in Russia starting around next year.

According to khoahoc.tv